Ellen Holm Nielsen
Corporate Officer/Principal chez University of Southern Denmark
Postes actifs de Ellen Holm Nielsen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Southern Denmark | Corporate Officer/Principal | - | - |
| University of California, Berkeley | Corporate Officer/Principal | - | - |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 14/08/2009 | - |
| University of Copenhagen | Corporate Officer/Principal | - | - |
Historique de carrière de Ellen Holm Nielsen
Anciens postes connus de Ellen Holm Nielsen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Profylakse ApS
 Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Directeur/Membre du Conseil | - | 22/11/2013 |
Statistiques
Internationale
| Danemark | 4 |
| Etats-Unis | 3 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Profylakse ApS
Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Health Technology |
- Bourse
- Insiders
- Ellen Holm Nielsen
- Expérience